Bringing GPT-Rosalind to academic research labs

PUBLISHER ARTICLE PREVIEW

From the original article

Introducing the Rosalind Academic Plan, offering eligible labs sponsored access to GPT‑Rosalind and tools for life sciences discovery.

We’re introducing the Rosalind Academic Plan to help more academic scientists access GPT‑Rosalind⁠, our dedicated life sciences model, which combines frontier reasoning with Rosalind workbench⁠ that enables specialized tool orchestration across medicinal chemistry, genomics, wet-lab assistance, and other scientific applications. Eligible labs can receive up to 30 Business Standard seats at no cost for up to 12 months, with access to GPT‑Rosalind subject to trusted-access approval.

Academic research creates knowledge that entire fields build on. Work that begins with a fundamental question about biology can eventually change how we diagnose disease, develop medicines, or grow food. But those advances depend on scientists having the resources to explore ideas, test them, and share what they learn.

Accelerating scientific discovery is central to OpenAI’s mission of ensuring that artificial general intelligence benefits all of humanity. With this plan, we’re investing in the scientists doing that foundational work—helping more labs combine their expertise and judgment with AI tools built for life sciences research.

Many of the advances we rely on today grew out of years of basic research.

The Human Genome Project helped launch modern genomics, transforming medicine, diagnostics, and biotechnology.

Curiosity-driven work on bacterial immune systems led to CRISPR-Cas9, which revolutionized genome editing and is now advancing research in cancer, inherited disease, agriculture, and biotechnology. Decades of university research on mRNA also laid the groundwork for COVID-19 vaccines and a new generation of vaccines and therapies.

Academic research has always laid the groundwork for advances in medicine and biotechnology. By helping more scientists combine their scientific expertise and judgment with the advanced specialized reasoning of GPT‑Rosalind, we hope to support discoveries whose benefits reach far beyond the lab.

OpenAI is committed to enabling academic researchers to pursue their scientific ambitions. Distinguished academic labs are already exploring how GPT‑Rosalind can support work ranging from protein design to understanding neurodegeneration. These examples show where researchers are applying the model within their scientific workflows.

Gathering drug-property evidence to support modeling how medicines move through the body and produce effects.

With the new Rosalind Academic Plan, academic researchers can bring GPT‑Rosalind and Rosalind Workbench to their lab with greater flexibility and harness frontier model intelligence for scientific research.